Works matching IS 09441174 AND DT 2020 AND VI 55 AND IP 6

Results: 9
    1
    2
    3
    4
    5

    JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study.

    Published in:
    2020
    By:
    • Takehara, Tetsuo;
    • Chayama, Kazuaki;
    • Kurosaki, Masayuki;
    • Yatsuhashi, Hiroshi;
    • Tanaka, Yasuhito;
    • Hiramatsu, Naoki;
    • Sakamoto, Naoya;
    • Asahina, Yasuhiro;
    • Nozaki, Akito;
    • Nakano, Toshikazu;
    • Hagiwara, Yosuke;
    • Shimizu, Hiroko;
    • Yoshida, Hiroki;
    • Huang, Yuhan;
    • Biermer, Michael;
    • Vijgen, Leen;
    • Hayashi, Norio
    Publication type:
    journal article
    6
    7
    8

    Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial.

    Published in:
    2020
    By:
    • Kudo, Masatoshi;
    • Okusaka, Takuji;
    • Motomura, Kenta;
    • Ohno, Izumi;
    • Morimoto, Manabu;
    • Seo, Satoru;
    • Wada, Yoshiyuki;
    • Sato, Shinpei;
    • Yamashita, Tatsuya;
    • Furukawa, Masayuki;
    • Aramaki, Takeshi;
    • Nadano, Seijin;
    • Ohkawa, Kazuyoshi;
    • Fujii, Hirofumi;
    • Kudo, Toshihiro;
    • Furuse, Junji;
    • Takai, Hiroki;
    • Homma, Gosuke;
    • Yoshikawa, Reigetsu;
    • Zhu, Andrew X.
    Publication type:
    journal article
    9